| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
T2 Biosystems, Inc. (TTOO) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 54 sells. TTOO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2020 | Goldman Sachs & Co. LLC | 10% Owner | Sell | 41,128 | $0.62 | $25,657.21 | - | |
| May 19, 2020 | Jones Adrian M | Director | Sell | 41,128 | $0.62 | $25,657.21 | - | |
| Feb 24, 2020 | Sprague John M | Chief Financial Officer | Sale+OE | 4,166 | $0.82 | $3,416.12 | -15.8% | |
| Feb 24, 2020 | Barclay Alec | SVP, Operations | Sale+OE | 5,808 | $0.82 | $4,762.56 | -11.1% | |
| Feb 24, 2020 | Gibbs Michael Terrence | General Counsel | Sale+OE | 5,808 | $0.82 | $4,762.56 | -8.7% | |
| Feb 24, 2020 | Lowery Thomas J. | Chief Scientific Officer | Sale+OE | 5,808 | $0.82 | $4,762.56 | -7.8% | |
| Feb 11, 2020 | Lowery Thomas J. | Chief Scientific Officer | Sale+OE | 3,200 | $0.77 | $2,464.00 | -4.7% | |
| Feb 11, 2020 | Gibbs Michael Terrence | General Counsel | Sale+OE | 3,200 | $0.77 | $2,464.00 | -5.4% | |
| Feb 3, 2020 | McDonough John | Director | Sell | 23,754 | $0.88 | $20,903.52 | -4.6% | |
| Feb 3, 2020 | Gibbs Michael Terrence | General Counsel | Sell | 3,283 | $0.88 | $2,889.04 | -5.7% |